reference/35141043

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35141043

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	597
issn	0278-0232 1099-1069
issueIdentifier	3
pageRange	594-597
publicationName	Hematological Oncology
startingPage	594
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ec049999c1bac22b3f8220a57e746f59 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a89d28286717224be1bfb93bd1dbe7a7
bibliographicCitation	Kai Sun, Wen‐Min Chen, Xu Wang, Xiao‐Su Zhao, Ling‐Di Li, Yue Hao, Jun Wang, Nan Xu, Qian Jiang, Hao Jiang, Lan‐Ping Xu, Yu Wang, Xiao‐Hui Zhang, Xiao‐Jun Huang, Ya‐Zhen Qin. Author response for "Outcome and molecular measurable residual disease monitoring in adult B‐cell acute lymphoblastic leukemia patients with MEF2D fusions". 2022 Nov 13;(). doi: 10.1002/hon.3114/v2/response1.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4718b93f102e5798a2de9a7812ce010 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1253-7465 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2a7289e2bb99c280a9271dd27f0106a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9dec973c88039cc4068f5cda6609e964 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8394d9e72a8c9a1cce8201f851a8609c http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1548-0946 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dccd0db867232f605d18229d804811e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d5b939e388705df43dc63aed3c39fbe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b251d5144bb4e0c877b9e69022780d97 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6f8e026197bb27e129a4edbdcad3fd1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f014e4aa0b353facebab4e17e5a005ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8fe3dead9bae1056dfcebec63c2c918 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e2386cbf6b5c69355191444d81506f11 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b60a241a964ff100e80c669089e56863 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ce3af99282062d0e62d1a7922479eff
date	2022-12-19^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/36516881 https://doi.org/10.1002/hon.3114 https://doi.org/10.1002/hon.3114/v2/response1
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4074 https://portal.issn.org/resource/ISSN/0278-0232 https://portal.issn.org/resource/ISSN/1099-1069
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Author response for "Outcome and molecular measurable residual disease monitoring in adult B‐cell acute lymphoblastic leukemia patients with MEF2D fusions"
discusses	http://id.nlm.nih.gov/mesh/M0205081 http://id.nlm.nih.gov/mesh/M0581097
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015452Q000628 http://id.nlm.nih.gov/mesh/D015452Q000235 http://id.nlm.nih.gov/mesh/D054198Q000628 http://id.nlm.nih.gov/mesh/D015452Q000175 http://id.nlm.nih.gov/mesh/D054198Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D064326Q000235 http://id.nlm.nih.gov/mesh/D018365 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7946357376b96872cf5a0434d5c175bf

Showing number of triples: 1 to 50 of 50.